Dan Manak joins Phesi to accelerate its expansion of big data based, artificial intelligence driven products and services supporting clinical development organizations around the world.
what Phesi is offering is of extremely high value. I am truly looking forward to supporting the team and our growing client list globally
EAST LYME, Conn. (PRWEB)
January 16, 2020
Phesi is delighted to announce the appointment of Dan Manak to the role of Executive Director for Business Development.
Dan is based in the US and has been working in pharma and clinical research for over 20 years, selling advanced clinical data analytics and AI technology and services to sponsor companies, enabling site selection and site management. On his appointment Dan said “to be representing products and services that involve AI for protocol development, study startup and site selection- well, to say I’m excited doesn’t really capture the whole of it. I know well that what Phesi is selling is needed, and similar to AI applied in clinical data analytics, what Phesi is offering is of extremely high value. I am truly looking forward to supporting the team and our growing client list globally.“
Share article on social media or email: